Accueil>>Signaling Pathways>> PROTAC>>NH2-PEG5-OH

NH2-PEG5-OH

Catalog No.GC61407

NH2-PEG5-OH est un lieur PROTAC À base de PEG qui peut être utilisé dans la synthèse des PROTAC. NH2-PEG5-OH est également un lieur PEG ADC À 5 unités non clivable utilisé dans la synthèse de conjugués anticorps-médicament (ADC).

Products are for research use only. Not for human use. We do not sell to patients.

NH2-PEG5-OH Chemical Structure

Cas No.: 34188-11-9

Taille Prix Stock Qté
100 mg
50,00 $US
En stock
500 mg
101,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

NH2-PEG5-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. NH2-PEG5-OH is also a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[2].

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[2].

[1]. Nathanael Gray, et al. Bifunctional molecules for degradation of egfr and methods of use. WO2017185036A1. [2]. Nianhe Han, et al. Derivatives of dolastatin 10 and uses thereof. WO2016192527A1.

Avis

Review for NH2-PEG5-OH

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for NH2-PEG5-OH

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.